These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 4042271)
1. Characterization of a microsomal fraction from rat small intestine for metabolic activation of some promutagens. Walters JM; Combes RD Carcinogenesis; 1985 Oct; 6(10):1415-20. PubMed ID: 4042271 [TBL] [Abstract][Full Text] [Related]
2. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase. Walters JM; Combes RD Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a methodology for the use of preparations from rat small intestine in the Salmonella/microsome assay. Walters JM; Combes RD Mutat Res; 1983 Aug; 113(5):393-402. PubMed ID: 6348524 [TBL] [Abstract][Full Text] [Related]
4. Activation of benzo(a)pyrene and 2-acetamidofluorene to mutagens by microsomal preparations from different animal species: role of cytochrome P-450 and P-448. Ioannides C; Parkinson C; Parke DV Xenobiotica; 1981 Oct; 11(10):701-8. PubMed ID: 6275616 [TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver. Shimada T; Okuda Y Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745 [TBL] [Abstract][Full Text] [Related]
6. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines. Fouarge M; Mercier M; Poncelet F Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544 [TBL] [Abstract][Full Text] [Related]
7. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. Hales BF Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774 [TBL] [Abstract][Full Text] [Related]
8. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Fitzsimmons ME; Collins JM Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057 [TBL] [Abstract][Full Text] [Related]
9. Effects of phenobarbital and methylcholanthrene on hepatic mixed-function-oxidase activities in hamsters. Tucker AN; Tang T J Environ Pathol Toxicol; 1979; 2(3):613-23. PubMed ID: 422927 [TBL] [Abstract][Full Text] [Related]
10. Preliminary studies on the ability of Drosophila microsomal preparations to activate mutagens and carcinogens. Baars AJ; Blijleven WG; Mohn GR; Natarajan AT; Breimer DD Mutat Res; 1980 Sep; 72(2):257-64. PubMed ID: 6777691 [TBL] [Abstract][Full Text] [Related]
11. Enhanced pulmonary and intestinal activation of procarcinogens and mutagens after chronic ethanol consumption in the rat. Seitz HK; Garro AJ; Lieber CS Eur J Clin Invest; 1981 Feb; 11(1):33-8. PubMed ID: 6783427 [TBL] [Abstract][Full Text] [Related]
12. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver. Aune T; Vanderslice RR; Croft JE; Dybing E; Bend JR; Philpot RM Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056 [TBL] [Abstract][Full Text] [Related]
13. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9. Johnson TE; Umbenhauer DR; Galloway SM Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047 [TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2AA) in rat liver and gut. Carrière V; de Waziers I; Courtois YA; Leroux JP; Beaune PH Mutat Res; 1992 Jul; 268(1):11-20. PubMed ID: 1378177 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938 [TBL] [Abstract][Full Text] [Related]
16. Microsomal metabolism of 2-acetylaminofluorene, role in mutagenicity and carcinogenicity. Roberfroid M; Razzouk C; Agazzi-Léonard E; Batardy-Grégoire M; Poncelet F; Mercier M Adv Exp Med Biol; 1981; 136 Pt B():921-9. PubMed ID: 7344520 [No Abstract] [Full Text] [Related]
17. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver. Ong T; Mukhtar M; Wolf CR; Zeiger E J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130 [TBL] [Abstract][Full Text] [Related]
18. Conversion of procarcinogens to mutagens by the S-9 fraction from the liver of rainbow trout (Salmo gairdneri): inducibility with PCB, 3-methylcholanthrene and phenobarbital and inhibition by metyrapone and alpha-naphthoflavone. Miyauchi M Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(2):363-7. PubMed ID: 6151468 [TBL] [Abstract][Full Text] [Related]
19. Activation and effects of the food-derived heterocyclic amines in extrahepatic tissues. Overvik E; Hellmold H; Branting C; Gustafsson JA Princess Takamatsu Symp; 1995; 23():123-33. PubMed ID: 8844803 [TBL] [Abstract][Full Text] [Related]
20. Cytochrome P-450 in the activation and inactivation of carcinogens. Greim H; Czygan P; Garro AJ; Hutterer F; Schaffner F; Popper H Adv Exp Med Biol; 1975; 58(00):103-15. PubMed ID: 1155249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]